ロード中...
培美曲塞在晚期非小细胞肺癌二线及以上治疗中的疗效分析
BACKGROUND AND OBJECTIVE: Pemetrexed is a standard second-line therapy in advanced non-small cell lung cancer (NSCLC). Currently, cytotoxic treatments beyond second-line therapy are not available. This study evaluated the efficacy and safety of pemetrexed as a salvage regimen in heavily pretreated p...
保存先:
| 出版年: | Zhongguo Fei Ai Za Zhi |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
中国肺癌杂志编辑部
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5999869/ https://ncbi.nlm.nih.gov/pubmed/22429582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2012.03.08 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|